BrainCool is a Lund-based medical technology company developing advanced medical cooling systems for the treatment of stroke, cardiac arrest, and chemotherapy side effects. Its three products — IQool System, RhinoChill, and Cooral — use targeted temperature management to reduce brain damage and oral mucositis. Listed on Nasdaq First North, BrainCool has approximately 20 employees and is running two pivotal clinical studies (PRINCESS 2 for cardiac arrest and COTTIS 2 for stroke).
braincool.sePart of: Skåne Startup map